Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 44 results:
Author Title Type [ Year(Asc)]
Filters: Author is Ruigomez, A.  [Clear All Filters]
2021
A. Ruigomez, Plana, E., Gilsenan, A., Fortuny, J., Cainzos-Achirica, M., Flynn, R. W. V., MacDonald, T. M., Garcia-Rodriguez, L., Ziemiecki, R., and Andrews, E. B., “Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride”, Drug Saf, 2021.
2019
L. A. Garcia Rodriguez, Martin-Perez, M., Vora, P., Roberts, L., Balabanova, Y., Brobert, G., Fatoba, S., Suzart-Woischnik, K., Schaefer, B., and Ruigomez, A., “Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK”, BMJ Open, vol. 9, p. e031341, 2019.
A. Gilsenan, Fortuny, J., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., Harding, A., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Odsbu, I., Plana, E., Ruigomez, A., Schink, T., Ziemiecki, R., and Andrews, E. B., “Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study”, Drug Saf, 2019.
J. Fortuny, Gilsenan, A., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Plana, E., Ruigomez, A., Schink, T., Ziemiecki, R., and Andrews, E. B., “Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350”, Drug Saf, 2019.
2016
C. Huerta, Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., De Bruin, M. L., Slattery, J., de Groot, M. C., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., Garcia-Rodriguez, L. A., Johansson, S., de Vries, F., Schlienger, R. G., Reynolds, R. F., Klungel, O. H., and de Abajo, F. J., “Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
R. Brauer, Ruigomez, A., Downey, G., Bate, A., Rodriguez, L. A. Garcia, Huerta, C., Gil, M., de Abajo, F., Requena, G., Alvarez, Y., Slattery, J., de Groot, M., Souverein, P., Hesse, U., Rottenkolber, M., Schmiedl, S., de Vries, F., Tepie, M. F., Schlienger, R., Smeeth, L., Douglas, I., Reynolds, R., and Klungel, O., “Prevalence of antibiotic use: a comparison across various European health care data sources”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 11-20, 2016.
R. Brauer, Ruigomez, A., Klungel, O., Reynolds, R., M. Tepie, F., Smeeth, L., and Douglas, I., “The risk of acute liver injury among users of antibiotic medications: a comparison of case-only studies”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 39-46, 2016.
2014
A. Ruigomez, Brauer, R., Rodriguez, L. A., Huerta, C., Requena, G., Gil, M., de Abajo, F., Downey, G., Bate, A., Tepie, M. F., de Groot, M., Schlienger, R., Reynolds, R., and Klungel, O., “Ascertainment of acute liver injury in two European primary care databases”, Eur J Clin Pharmacol, vol. 70, pp. 1227-35, 2014.
2009
A. Ruigomez, Masso-Gonzalez, E. L., Johansson, S., Wallander, M. A., and Garcia-Rodriguez, L. A., “Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality”, Br J Gen Pract, vol. 59, pp. e78-86, 2009.
A. Ruigomez, Wallander, M. A., Johansson, S., and Rodriguez, L. A., “Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?”, Dig Dis Sci, vol. 54, pp. 1079-86, 2009.
L. A. Rodriguez, Tolosa, L. B., Ruigomez, A., Johansson, S., and Wallander, M. A., “Rheumatoid arthritis in UK primary care: incidence and prior morbidity”, Scand J Rheumatol, vol. 38, pp. 173-7, 2009.
2008
L. A. Garcia Rodriguez, Ruigomez, A., Martin-Merino, E., Johansson, S., and Wallander, M. A., “Relationship between gastroesophageal reflux disease and COPD in UK primary care”, Chest, vol. 134, pp. 1223-1230, 2008.
2007
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., and Dent, J., “Endoscopic findings in a cohort of newly diagnosed gastroesophageal reflux disease patients registered in a UK primary care database”, Dis Esophagus, vol. 20, pp. 504-9, 2007.
M. A. Wallander, Johansson, S., Ruigomez, A., Rodriguez, L. A. Garcia, and Jones, R., “Morbidity associated with sleep disorders in primary care: a longitudinal cohort study”, Prim Care Companion J Clin Psychiatry, vol. 9, pp. 338-45, 2007.
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., Wallander, M. A., and Edvardsson, N., “Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation”, Clin Cardiol, vol. 30, pp. 624-8, 2007.
M. A. Wallander, Johansson, S., Ruigomez, A., and Rodriguez, L. A. Garcia, “Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity”, Int J Clin Pract, vol. 61, pp. 1663-70, 2007.
2006
L. A. Garcia Rodriguez, Ruigomez, A., and Panes, J., “Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease”, Gastroenterology, vol. 130, pp. 1588-94, 2006.
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., and Jones, R., “Chest pain in general practice: incidence, comorbidity and mortality”, Fam Pract, vol. 23, pp. 167-74, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Dent, J., “Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care”, Curr Med Res Opin, vol. 22, pp. 1661-8, 2006.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., and Eklund, S., “Esophageal stricture: incidence, treatment patterns, and recurrence rate”, Am J Gastroenterol, vol. 101, pp. 2685-92, 2006.
2005
A. Ruigomez, Rodriguez, L. A., Wallander, M. A., Johansson, S., Thomas, M., and Price, D., “Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice”, Chest, vol. 128, pp. 85-93, 2005.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK”, BMC Cardiovasc Disord, vol. 5, p. 20, 2005.
2004
G. Ronquist, Rodriguez, L. A., Ruigomez, A., Johansson, S., Wallander, M. A., Frithz, G., and Svardsudd, K., “Association between captopril, other antihypertensive drugs and risk of prostate cancer”, Prostate, vol. 58, pp. 50-6, 2004.
A. Ruigomez, Rodriguez, L. A. Garcia, Wallander, M. A., Johansson, S., Graffner, H., and Dent, J., “Natural history of gastro-oesophageal reflux disease diagnosed in general practice”, Aliment Pharmacol Ther, vol. 20, pp. 751-60, 2004.
2003
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., and Wallander, M. A., “Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?”, Maturitas, vol. 44, pp. 133-40, 2003.
J. Hollowell, Ruigomez, A., Johansson, S., Wallander, M. A., and Garcia-Rodriguez, L. A., “The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom”, Br J Gen Pract, vol. 53, pp. 312-4, 2003.
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
2002
A. Kennerfalk, Ruigomez, A., Wallander, M. A., Wilhelmsen, L., and Johansson, S., “Geriatric drug therapy and healthcare utilization in the United kingdom”, Ann Pharmacother, vol. 36, pp. 797-803, 2002.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A., “Incidence of chronic atrial fibrillation in general practice and its treatment pattern”, J Clin Epidemiol, vol. 55, pp. 358-63, 2002.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation”, BMC Cardiovasc Disord, vol. 2, p. 5, 2002.
S. Johansson, Wallander, M. A., Ruigomez, A., and Garcia, R., “Treatment patterns among newly diagnosed heart failure patients in general practice”, Eur J Clin Pharmacol, vol. 57, pp. 813-7, 2002.
2001
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Gender and drug treatment as determinants of mortality in a cohort of heart failure patients”, Eur J Epidemiol, vol. 17, pp. 329-35, 2001.
S. Johansson, Wallander, M. A., Ruigomez, A., and Rodriguez, L. A. Garcia, “Incidence of newly diagnosed heart failure in UK general practice”, Eur J Heart Fail, vol. 3, pp. 225-31, 2001.
2000
A. Ruigomez, Rodriguez, L. A. Garcia, Dev, V. J., Arellano, F., and Raniwala, J., “Are schizophrenia or antipsychotic drugs a risk factor for cataracts?”, Epidemiology, vol. 11, pp. 620-3, 2000.
L. A. Garcia Rodriguez, Ruigomez, A., Wallander, M. A., Johansson, S., and Olbe, L., “Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome”, Scand J Gastroenterol, vol. 35, pp. 306-11, 2000.
A. Ruigomez, Rodriguez, L. A. Garcia, Hasselgren, G., Johansson, S., and Wallander, M. A., “Overall mortality among patients surviving an episode of peptic ulcer bleeding”, J Epidemiol Community Health, vol. 54, pp. 130-3, 2000.
1999
L. A. Rodriguez and Ruigomez, A., “Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study”, Bmj, vol. 318, pp. 565-6, 1999.
A. Ruigomez, Wallander, M. A., Johansson, S., and Rodriguez, L. A. Garcia, “One-year follow-up of newly diagnosed irritable bowel syndrome patients”, Aliment Pharmacol Ther, vol. 13, pp. 1097-102, 1999.
L. A. Garcia Rodriguez and Ruigomez, A., “Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed”, Epidemiology, vol. 10, pp. 228-32, 1999.
A. Ruigomez, Rodriguez, L. A. Garcia, Cattaruzzi, C., Troncon, M. G., Agostinis, L., Wallander, M. A., and Johansson, S., “Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes”, Am J Epidemiol, vol. 150, pp. 476-81, 1999.
1998
L. A. Garcia Rodriguez, Ruigomez, A., Hasselgren, G., Wallander, M. A., and Johansson, S., “Comparison of mortality from peptic ulcer bleed between patients with or without peptic ulcer antecedents”, Epidemiology, vol. 9, pp. 452-6, 1998.
A. Ruigomez and Rodriguez, L. A. Garcia, “Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor”, Eur J Epidemiol, vol. 14, pp. 439-45, 1998.
1997
L. A. Garcia Rodriguez and Ruigomez, A., “Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?”, Epidemiology, vol. 8, pp. 571-4, 1997.
L. A. Garcia Rodriguez, Ruigomez, A., and Jick, H., “A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom”, Pharmacotherapy, vol. 17, pp. 721-8, 1997.
[Page last reviewed 4 May 2021]